Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report

Hiroshi Kataoka,Toshio Mochizuki,Taro Akihisa,Kentaro Kawasoe,Keiko Kawachi,Shiho Makabe,Anri Sawada,Shun Manabe,Masayo Sato,Nobuyuki Amemiya,Michihiro Mitobe,Takafumi Akanuma,Yasuko Ito,Takahiro Inoue,Tomo Suzuki,Katsuomi Matsui,Takahito Moriyama,Shigeru Horita,Mamiko Ohara,Kazuho Honda,Kosaku Nitta

Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report

2019

AbstractRationale:Adult-onset hepatitis B virus-associated membranoproliferative glomerulonephritis (HBV-MPGN) is generally refractory, and an effective treatment for this condition has not been established. The indications for steroids in HBV-MPGN are an important clinical concern.Patient concerns:

Keywords:

Diabetes mellitus
Prednisolone
Physical therapy
Gastroenterology
Medicine
Entecavir
Hepatitis B virus
Internal medicine
Membranoproliferative glomerulonephritis
Refractory
effective treatment
Hepatitis B

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations